Search

everythinglearnresearchcommunity

for

Search:↓

TNF-alpha inhibitors can cause various immune-related skin issues.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.